Evidence map›Paper›PMID 31655616›Full record

ArticleOrphanet journal of rare diseases2019

Neutral lipid storage disease with myopathy in China: a large multicentric cohort study.

Wei Zhang, Bing Wen, Jun Lu, Yawen Zhao, Daojun Hong, Zhe Zhao, Cheng Zhang, Yuebei Luo, Xueliang Qi, Yingshuang Zhang and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. A NovelMolecular syndromology · 2025
    Article
  4. Case Report: PathogenicFrontiers in genetics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. A novel homozygous missense mutation inMolecular genetics and metabolism reports · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Wei ZhangDepartment of Neurology, Peking University First Hospital, No.8 Xishiku Street, West District, Beijing, 100034, China.
Bing WenDepartment of Neurology, Qilu Hospital of Shandong University, No. 107, West Wenhua Road, Jinan, 250012, Shandong, China.
Jun LuDepartment of Neurology, Huashan Hospital of Fudan University, Shanghai, People's Republic of China.
Yawen ZhaoDepartment of Neurology, Peking University First Hospital, No.8 Xishiku Street, West District, Beijing, 100034, China.
Daojun HongDepartment of Neurology, Peking University People's Hospital, Beijing, People's Republic of China.
Zhe ZhaoDepartment of Neurology, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei province, People's Republic of China.
Cheng ZhangDepartment of Neurology, the First Affiliated Hospital of Sun yat-sen University, Guangzhou, Guangdong province, People's Republic of China.
Yuebei LuoDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan province, People's Republic of China.
Xueliang QiDepartment of Neurology, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi province, People's Republic of China.
Yingshuang ZhangDepartment of Neurology, Third Hospital, Peking University, Beijing, People's Republic of China.
Xueqin SongDepartment of Neurology, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei province, People's Republic of China.
Yuying ZhaoDepartment of Neurology, Qilu Hospital of Shandong University, No. 107, West Wenhua Road, Jinan, 250012, Shandong, China.
Chongbo ZhaoDepartment of Neurology, Huashan Hospital of Fudan University, Shanghai, People's Republic of China.
Jing HuDepartment of Neurology, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei province, People's Republic of China.
Huan YangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan province, People's Republic of China.
Zhaoxia WangDepartment of Neurology, Peking University First Hospital, No.8 Xishiku Street, West District, Beijing, 100034, China.
Chuanzhu YanDepartment of Neurology, Qilu Hospital of Shandong University, No. 107, West Wenhua Road, Jinan, 250012, Shandong, China. chuanzhuyan@163.com.
Yun YuanDepartment of Neurology, Peking University First Hospital, No.8 Xishiku Street, West District, Beijing, 100034, China. yuanyun2002@126.com.ORCID 0000-0003-3282-9123
Peking University · CNHebei Medical University · CNCentral South University · CNFudan University · CNQilu Hospital of Shandong University · CNNanchang University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeutral lipid storage disease with myopathy (NLSDM) is a rare clinical heterogeneous disorder caused by mutations in the patatin-like phospholipase domain-containing 2 (PNPLA2) gene. NLSDM usually presents skeletal myopathy, cardiomyopathy and the multiple organs dysfunction. Around 50 cases of NLSDM have been described worldwide, whereas the comprehensive understanding of this disease are still limited. We therefore recruit NLSDM patients from 10 centers across China, summarize the clinical, muscle imaging, pathological and genetic features, and analyze the genotype-phenotype relationship.

resultsA total of 45 NLSDM patients (18 men and 27 women) were recruited from 40 unrelated families. Thirteen patients were born from consanguineous parents. The phenotypes were classified as asymptomatic hyperCKemia (2/45), pure skeletal myopathy (18/45), pure cardiomyopathy (4/45), and the combination of skeletal myopathy and cardiomyopathy (21/45). Right upper limb weakness was the early and prominent feature in 61.5% of patients. On muscle MRI, the long head of the biceps femoris, semimembranosus and adductor magnus on thighs, the soleus and medial head of the gastrocnemius on lower legs showed the most severe fatty infiltration. Thirty-three families were carrying homozygous mutations, while seven families were carrying compound heterozygous mutations. A total of 23 mutations were identified including 11 (47.8%) point mutations, eight (34.8%) deletions and four (17.4%) insertions. c.757 + 1G > T, c.245G > A and c.187 + 1G > A were the three most frequent mutations. Among four groups of phenotypes, significant differences were shown in disease onset (< 20 years versus ≥20 years old, p = 0.003) and muscle pathology (with rimmed vacuoles versus without rimmed vacuoles, p = 0.001). PNPLA2 mutational type or functional defects did not show great impact on phenotypes.

conclusionWe outline the clinical and genetic spectrum in a large cohort of NLSDM patients. Selective muscle fatty infiltration on posterior compartment of legs are characteristic of NLSDM. Chinese patients present with distinctive and relative hotspot PNPLA2 mutations. The disease onset age and pathological appearance of rimmed vacuoles are proved to be related with the clinical manifestations. The phenotypes are not strongly influenced by genetic defects, suggesting the multiple environmental risk factors in the development of NLSDM.

Indexed as

ChinaCohort StudiesFemaleGenetic Predisposition to DiseaseHumansLipid Metabolism, Inborn ErrorsMaleMuscle, SkeletalMuscular DiseasesCardiomyopathyNeutral lipid storage disease with myopathyPatatin-like phospholipase domain-containing 2Rimmed vacuoleSkeletal myopathy

Identifiers

PMID31655616
PMCPMC6815004
OpenAlexW2981409839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.